Akhilesh Kumar Selected Research

Akhilesh Kumar Research Topics

Disease

9	Neoplasms (Cancer) 12/2023 - 03/2009
7	Fibrosis (Cirrhosis) 11/2023 - 01/2010
7	Visceral Leishmaniasis (Kala Azar) 12/2022 - 01/2017
4	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2017
3	Wounds and Injuries (Trauma) 01/2023 - 01/2021
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2012
3	Body Weight (Weight, Body) 01/2022 - 06/2015
3	Ascites 03/2009 - 05/2008
2	Glaucoma 04/2024 - 01/2013
2	Bites and Stings (Sting) 02/2024 - 01/2022
2	Rheumatoid Arthritis 01/2024 - 06/2021
2	COVID-19 01/2024 - 12/2022
2	Breast Neoplasms (Breast Cancer) 12/2023 - 06/2023
2	Inflammation (Inflammations) 11/2023 - 07/2010
2	Acute Kidney Injury (Acute Renal Failure) 09/2023 - 01/2022
2	Hemorrhage 09/2023 - 01/2022
2	Multiple Myeloma 01/2023 - 11/2022
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2021
2	Necrosis 12/2021 - 07/2010
2	Hemangioma (Angioma) 07/2021 - 06/2021
2	Infections 01/2021 - 10/2018
2	Communicable Diseases (Infectious Diseases) 01/2017 - 04/2014
2	Hypertrophy 01/2017 - 06/2015
2	Teratogenesis 07/2015 - 08/2012
2	Ehrlich Tumor Carcinoma 11/2009 - 03/2009
2	Carcinoma (Carcinomatosis) 02/2009 - 05/2008
2	Lymphoma (Lymphomas) 02/2009 - 05/2008
1	Malnutrition (Nutritional Deficiencies) 05/2024
1	Postmenopausal Osteoporosis 03/2024
1	Hematoma 09/2023
1	Lung Neoplasms (Lung Cancer) 03/2023
1	Carcinogenesis 03/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Ischemia 01/2023
1	Hypoxia (Hypoxemia) 12/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2022
1	Ganglion Cysts (Ganglion) 09/2022
1	Human Influenza (Influenza) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Hemoptysis 01/2022
1	Cytopenia 01/2022
1	Heart Injuries 01/2022

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2022 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2010
4	EpitopesIBA 12/2022 - 01/2017
4	Peptides (Polypeptides)IBA 12/2022 - 05/2008
3	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
3	VaccinesIBA 01/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 10/2018 - 01/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2015
2	Matrix Metalloproteinases (MMPs)IBA 04/2024 - 07/2010
2	Neuroprotective AgentsIBA 04/2024 - 06/2018
2	Estrogens (Estrogen)FDA Link 03/2024 - 05/2010
2	Antivenins (Antivenoms)IBA 02/2024 - 09/2023
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2023 - 01/2022
2	CollagenIBA 11/2023 - 01/2022
2	AntigensIBA 11/2022 - 01/2017
2	EnzymesIBA 01/2019 - 03/2010
2	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 06/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2015
2	Pyroglutamate Hydrolase (5 Oxoprolinase)IBA 03/2015 - 03/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009 - 03/2009
1	SolutionsIBA 05/2024
1	Janus Kinase InhibitorsIBA 01/2024
1	sigma Receptors (sigma Receptor)IBA 12/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023
1	buparvaquoneIBA 12/2023
1	Pravastatin (Pravachol)FDA LinkGeneric 11/2023
1	Imatinib Mesylate (Gleevec)FDA Link 06/2023
1	ChondroitinIBA 06/2023
1	Benzo(a)pyreneIBA 03/2023
1	HydrocarbonsIBA 03/2023
1	pyrazoleIBA 01/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2022
1	Complex MixturesIBA 12/2022
1	SuspensionsIBA 12/2022
1	B-Cell Maturation AntigenIBA 11/2022
1	Chimeric Antigen ReceptorsIBA 11/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2022
1	AntibodiesIBA 11/2022
1	Bromodeoxyuridine (BrdU)IBA 09/2022
1	5-ethynyl-2'-deoxyuridineIBA 09/2022
1	Viral RNAIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	VenomsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022

Therapy/Procedure

9	Therapeutics 01/2024 - 02/2016
3	Oral Administration 01/2022 - 11/2017
1	Artificial Respiration (Mechanical Ventilation) 12/2022
1	Subcutaneous Injections 01/2022